drugset / Trial / NCT00402987

Testing The Effectiveness Of Celecoxib In Patients With Painful Sore Throat

NCT00402987 ↗

Phase 3 Completed 269 enrolled Viatris Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

We are proposing a study in which we utilize and augment the sore throat pain model to assess the analgesic effectiveness of celecoxib compared to placebo in patients with painful pharyngitis under randomized, double-blind, placebo-controlled conditions.

Timeline

Start
2006-12-04
Primary completion
2007-11-15
Completion
2007-11-15

Outcome

Met primary endpoint

registry analysis (unspecified test); Celecoxib 100mg (Pooled) vs Placebo; p = 0.0003; Mean Difference (Final Values) 11.7 (95% CI 5.5 to 17.9) NCT00402987 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Celecoxib Other / unclassified 50 mg —
Subject Celecoxib Other / unclassified 100 mg —

Indications